Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Nicole Jenkinson

Physician Assistant Johnstown, PA Physician Assistant

NPI 1922669506 CMS profile 11029188

1 Tech Park Dr, Johnstown, PA 15901

Open in the dashboard

General payments

$5,011

214 records reported · program years 2021–2025

Research payments

$700

Paid to them · 5 records reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Nicole Jenkinson of Johnstown, PA is reported in the CMS Open Payments database as having received $5,011 across 214 general payments and $700 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 93rd percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,371 74
2024 General $1,260 50
2023 General $1,004 41
2023 Research $500 3
2022 General $989 37
2022 Research $200 2
2021 General $387 12

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Nicole Jenkinson
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Nicole Jenkinson were reported at $1,371. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Nicole Jenkinson Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $387 $132 $37–$438 $132
2022 $989 $155 $48–$522 $149
2023 $1,004 $167 $52–$557 $160
2024 $1,260 $178 $55–$600 $164
2025 $1,371 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $1,011 45 payments
  2. Boston Scientific Corporation $861 33 payments
  3. Inari Medical, Inc. $493 16 payments
  4. Novartis Pharmaceuticals Corporation $449 23 payments
  5. Stryker Corporation $341 16 payments
  6. Novo Nordisk Inc $295 6 payments
  7. AstraZeneca Pharmaceuticals LP $256 11 payments
  8. E.R. Squibb & Sons, L.L.C. $254 13 payments
  9. Abiomed $149 4 payments
  10. Amgen Inc. $126 8 payments
  11. Other $775 39 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $4,921 213 payments
  2. Education $90 1 payment
Products named General payments · program years 2021–2025
  1. LifeVest $1,011 45 payments
  2. CT THROMBECTOMY SYSTEM KIT $586 20 payments
  3. FLOWTRIEVER CATHETER, S $586 20 payments
  4. WATCHMAN Access System $290 10 payments
  5. FLOWTRIEVER $248 12 payments
  6. LEQVIO $226 11 payments
  7. FARXIGA $149 9 payments
  8. EMBLEM MRI S-ICD $142 4 payments
  9. VERQUVO $142 7 payments
  10. CAMZYOS $141 8 payments
  11. Other $2,133 95 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2021–2025
  1. ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $700 5 payments

Prescribing to Medicare patients

Part D · data year 2024 · 21 drugs

Part D claims

464

Median for Physician Assistant: 241

Drug cost

$74,400

Median for Physician Assistant: $4,110

Branded share of claims

36.2%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Eliquis Apixaban Brand 35 $25,035
Entresto Sacubitril/Valsartan Brand 12 $12,283
Farxiga Dapagliflozin Propanediol Brand 16 $9,346
Praluent Pen Alirocumab Brand 13 $8,658
Brilinta Ticagrelor Brand 12 $8,429
Ranolazine Er Ranolazine Brand 13 $6,732
Metoprolol Succinate Generic 47 $652
Atorvastatin Calcium Generic 46 $605
Amlodipine Besylate Generic 34 $470
Diltiazem 24hr Er (Cd) Diltiazem Hcl Brand 25 $387

The 10 drugs with the highest cost, of 21 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 11 billing codes

Paid by Medicare

$21,467

Medicare's payments for the services billed

Medicare patients

199

Average age 76

Services billed

363

87 women, 112 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 70%
Arthritis 59%
Heart failure 52%
Chronic kidney disease 46%
Diabetes 45%
Atrial fibrillation 45%
Depression 34%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 11 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
Wegovy
  • Novo Nordisk Inc $132
$132 — —
LEQVIO
  • Novartis Pharmaceuticals Corporation $76
$76 — —
VERQUVO
  • Merck Sharp & Dohme Corporation $42
$42 — —
JARDIANCE
  • Boehringer Ingelheim Pharmaceuticals, Inc. $36
$36 — —
Arcalyst
  • Kiniksa Pharmaceuticals International, plc $35
$35 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 11 in the dashboard with a free account

Records

219 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in Pennsylvania

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record